CCB Portal Please support MJHS Institute
Facebook Twitter YouTube LinkedIn

On-Demand Webinars:
Symptoms other than Pain

Note: Institutional group rates are available upon request.

$85 for all Four Webinars (Save $15)

Select type to purchase:

Or $25 as individual Webinars

 

Management of nausea and constipation in advanced illness – 0.75 Credit

Speaker
Speaker Name and Title:
Pauline Lesage, MD, LLM
Physician Educator
MJHS Institute for Innovation in Palliative Care

Funding Disclosure: No commercial funding has been accepted for the activity.

Purpose:
 The goal of this webinar is to review the etiology, pathophysiology, and management of nausea and constipation, two common symptoms in advanced illness.

Objectives:

    1. Describe the etiology and pathophysiology of nausea and constipation in patients with advanced illness
    2. Recognize the signs and symptoms associated with nausea and constipation, and assessment methods for both
    3. Identify pharmacologic and nonpharmacologic management strategies for nausea and constipation in the setting of advanced illness

Target Audience: palliative care specialists, pain specialists, primary care providers, nurse practitioners, registered nurses, advanced practice nurses, registered nurses with a specialty in palliative care/hospice, allied health professionals, fellows, residents, and medical students.

Criteria for Successful Completion:

    1. Attendance at entire session 
    2. Submission of completed evaluation form 
    3. Successful completion of a posttest (70% for physicians, non-physicians, and nurses)

Continuing Education Credits: 0.75

Release Date: March 1, 2018

Expiration Date: June 15, 2021 (for physicians and non-physicians); February 14, 2021 (for nurses)

Continuing Education Accreditation:

Physicians: This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Medical Society of the State of New York (MSSNY) through the joint providership of MSSNY and the MJHS Institute for Innovation in Palliative Care. MSSNY is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: MJHS Institute for Innovation in Palliative Care is an approved provider of continuing nursing education by The Alabama State Nurses Association, an accredited approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Disclosures
Pauline Lesage, MD, LLM, has no financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials. Any discussion of investigational or unlabeled uses of a product will be identified.

Russell K. Portenoy, MD, Faculty and Planner, has indicated a relationship with AstraZeneca Pharmaceuticals LP and Tabula Rasa for research support. 

No other Planning Committee Member has any disclosures.

Planning Committee Members
Lara Dhingra, PhD
Colleen Fleming-Damon, PhDc, ANP-BC, ACHPN, FT
Myra Glajchen, DSW
Helena Knotkova, PhD
Russell K. Portenoy, MD
Karen Richards, PhD, EdS
Wini Schein, BA

Select type to purchase:
 

management of anorexia/cachexia – 0.75 credit

Speaker
Speaker Name and Title:
Ebtesam Ahmed, PharmD, MS
Director of Pharmacy Internship
MJHS Institute for Innovation in Palliative Care
Associate Clinical Professor, St. John’s University

Funding Disclosure: No commercial funding has been accepted for the activity.

Purpose:
 The purpose of this webinar is to discuss the prevalence, clinical features, assessment, and management of anorexia/cachexia in patients with advanced life-threatening illness receiving palliative care.

Objectives:

  1. Discuss the prevalence and significance of anorexia/cachexia in patients receiving palliative care
  2. Recognize the clinical features and assessment criteria for anorexia/cachexia
  3. Identify the treatment options for anorexia/cachexia and recognize its impact on quality of life

Target Audience:  palliative care specialists, pain specialists, primary care providers, nurse practitioners, registered nurses, advanced practice nurses, registered nurses with a specialty in palliative care/hospice, allied health professionals, fellows, residents, and medical students

Criteria for Successful Completion:

    1. Attendance at entire session 
    2. Submission of completed evaluation form 
    3. Successful completion of a posttest (70% for physicians, non-physicians, and nurses)

Continuing Education Credits:  0.75

Release Date: March 1, 2018

Expiration Date: June 15, 2021 (for physicians and non-physicians); February 14, 2021 (for nurses)

Continuing Education Accreditation:

Physicians:  This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Medical Society of the State of New York (MSSNY) through the joint providership of MSSNY and the MJHS Institute for Innovation in Palliative Care. MSSNY is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses:  MJHS Institute for Innovation in Palliative Care is an approved provider of continuing nursing education by The Alabama State Nurses Association, an accredited approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Disclosures:
Ebtesam Ahmed, PharmD, MS, has no financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials. Any discussion of investigational or unlabeled uses of a product will be identified.

Russell K. Portenoy, MD, Faculty and Planner, has indicated a relationship with AstraZeneca Pharmaceuticals LP and Tabula Rasa for research support. 

No other Planning Committee Member has any disclosures.

Planning Committee Members
Lara Dhingra, PhD
Colleen Fleming-Damon, PhDc, ANP-BC, ACHPN, FT
Myra Glajchen, DSW
Helena Knotkova, PhD
Russell K. Portenoy, MD
Karen Richards, PhD, EdS
Wini Schein, BA

Select type to purchase:
 

assessment and management of dyspnea in advanced illness – 0.75 credit

Speaker
Speaker Name and Title:
Pauline Lesage, MD, LLM
Physician Educator
MJHS Institute for Innovation in Palliative Care

Funding Disclosure: No commercial funding has been accepted for the activity.

Purpose:
 The purpose of this webinar is to enable the learner to describe the complexity of dyspnea in the setting of advanced disease and the ways in which clinicians can remediate this frequent symptom. 

Objectives:

  1. Discuss the symptom of dyspnea in advanced illness
  2. Describe the assessment of dyspnea in advanced illness and its complexity
  3. Identify approaches to the management of dyspnea in the setting of advanced disease

Target Audience: palliative care specialists, pain specialists, primary care providers, nurse practitioners, registered nurses, advanced practice nurses, registered nurses with a specialty in palliative care/hospice, allied health professionals, fellows, residents, and medical students.

Criteria for Successful Completion:

    1. Attendance at entire session
    2. Submission of completed evaluation form
    3. Successful completion of a posttest (70% for physicians, non-physicians, and nurses)

Continuing Education Credits: 0.75

Release Date: March 1, 2018

Expiration Date: June 15, 2021 (for physicians and non-physicians); February 14, 2021 (for nurses)

Continuing Education Accreditation:

Physicians:  This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Medical Society of the State of New York (MSSNY) through the joint providership of MSSNY and the MJHS Institute for Innovation in Palliative Care. MSSNY is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses:  MJHS Institute for Innovation in Palliative Care is an approved provider of continuing nursing education by The Alabama State Nurses Association, an accredited approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Disclosures
Pauline Lesage, MD, LLM, has no financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials. Any discussion of investigational or unlabeled uses of a product will be identified.

Russell K. Portenoy, MD, Faculty and Planner, has indicated a relationship with AstraZeneca Pharmaceuticals LP and Tabula Rasa for research support. 

No other Planning Committee Member has any disclosures.

Planning Committee Members
Lara Dhingra, PhD
Colleen Fleming-Damon, PhDc, ANP-BC, ACHPN, FT
Myra Glajchen, DSW
Helena Knotkova, PhD
Russell K. Portenoy, MD
Karen Richards, PhD, EdS
Wini Schein, BA

Select type to purchase:
 

assessment and management of delirium – 0.75 credit

Speaker
Speaker Name and Title:
Pauline Lesage, MD, LLM
Physician Educator
MJHS Institute for Innovation in Palliative Care

Funding Disclosure: No commercial funding has been accepted for the activity.

Purpose:
 The purpose of this webinar is to review the epidemiology, etiology, clinical features, and management of delirium in the palliative care setting.

Objectives:

  1. Define delirium, its prevalence, categories, and etiology
  2. Recognize the clinical elements of delirium
  3. Discuss the management of delirium

Target Audience: palliative care specialists, pain specialists, primary care providers, nurse practitioners, registered nurses, advanced practice nurses, registered nurses with a specialty in palliative care/hospice, allied health professionals, fellows, residents, and medical students.

Criteria for Successful Completion:

    1. Attendance at entire session
    2. Submission of completed evaluation form
    3. Successful completion of a posttest (70% for physicians, non-physicians, and nurses; 80% for NYS Social Workers)

Continuing Education Credits: 0.75

Release Date: March 1, 2018

Expiration Date: June 15, 2021 (for physicians and non-physicians); February 14, 2021 (for nurses); January 31, 2019 (for NYS Social Workers)

Continuing Education Accreditation:

Physicians:  This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Medical Society of the State of New York (MSSNY) through the joint providership of MSSNY and the MJHS Institute for Innovation in Palliative Care. MSSNY is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses:  MJHS Institute for Innovation in Palliative Care is an approved provider of continuing nursing education by The Alabama State Nurses Association, an accredited approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Social Workers: MJHS Institute for Innovation in Palliative Care SW CPE is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #0242.

Disclosures
Pauline Lesage, MD, LLM, has no financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials. Any discussion of investigational or unlabeled uses of a product will be identified.

Russell K. Portenoy, MD, Faculty and Planner, has indicated a relationship with AstraZeneca Pharmaceuticals LP and Tabula Rasa for research support. 

No other Planning Committee Member has any disclosures.

Planning Committee Members
Lara Dhingra, PhD
Colleen Fleming-Damon, PhDc, ANP-BC, ACHPN, FT
Myra Glajchen, DSW
Helena Knotkova, PhD
Russell K. Portenoy, MD
Karen Richards, PhD, EdS
Wini Schein, BA

Select type to purchase: